Prophylactic treatment of haemophilia has been gaining acceptance as the optimal therapeutic option in an increasing number of haemophilia centres in the developed world in recent years. This paper focus on three aspects of prophylactic therapy: when to start treatment, venous access and the dose/dose interval. Evidence is in favour of prophylactic treatment to be started at an early age using either a peripheral vein with 1-2 injections per week and a successive increase in the frequency depending on the child and the veins, or, using a Port-A-Cath which allows a better prophylactic coverage by infusions preferably every second day in haemophilia A and every third day in haemophilia B
Summary: Long-term, continuous prophylaxis for haemophilia began at a modest scale during the 1950s ...
Background Prophylaxis is the gold standard for the treatment of children with severe hemophilia. In...
The aim of the thesis was to increase cost-effectiveness in prophylactic treatment of haemophilia. P...
At the haemophilia centre in Malmo, Sweden, regular prophylactic treatment is begun at 1-1 1/4 years...
Prophylaxis is defined as the regular administration of clotting factor concentrates to prevent blee...
Initiating prophylactic treatment at an early age is considered to be the optimal form of therapy fo...
Prophylaxis entails long-term continuous intravenous administration of concentrates of the deficient...
To summarize, prophylactic treatment of hemophilia begun at an early age has been gaining acceptance...
Data from prospective studies clearly demonstrate the efficacy of prophylactic treatment of haemophi...
This paper reviews the current status on recommendations or guidelines for primary prophylaxis based...
The hallmark of severe haemophilia, defined as a circulating level of factor (F) VIII (haemophilia A...
The practice of prophylactic treatment of boys with severe haemophilia has been evaluated in our cen...
Clinical experience over decades and numerous retrospective and, recently, also prospective studies ...
The preventive regular intravenous administration of factor VIII (FVIII) or IX (FIX) concentrates ha...
Haemophilia A is a sex-linked disorder characterised chiefly by recurrent, spontaneous joint and mus...
Summary: Long-term, continuous prophylaxis for haemophilia began at a modest scale during the 1950s ...
Background Prophylaxis is the gold standard for the treatment of children with severe hemophilia. In...
The aim of the thesis was to increase cost-effectiveness in prophylactic treatment of haemophilia. P...
At the haemophilia centre in Malmo, Sweden, regular prophylactic treatment is begun at 1-1 1/4 years...
Prophylaxis is defined as the regular administration of clotting factor concentrates to prevent blee...
Initiating prophylactic treatment at an early age is considered to be the optimal form of therapy fo...
Prophylaxis entails long-term continuous intravenous administration of concentrates of the deficient...
To summarize, prophylactic treatment of hemophilia begun at an early age has been gaining acceptance...
Data from prospective studies clearly demonstrate the efficacy of prophylactic treatment of haemophi...
This paper reviews the current status on recommendations or guidelines for primary prophylaxis based...
The hallmark of severe haemophilia, defined as a circulating level of factor (F) VIII (haemophilia A...
The practice of prophylactic treatment of boys with severe haemophilia has been evaluated in our cen...
Clinical experience over decades and numerous retrospective and, recently, also prospective studies ...
The preventive regular intravenous administration of factor VIII (FVIII) or IX (FIX) concentrates ha...
Haemophilia A is a sex-linked disorder characterised chiefly by recurrent, spontaneous joint and mus...
Summary: Long-term, continuous prophylaxis for haemophilia began at a modest scale during the 1950s ...
Background Prophylaxis is the gold standard for the treatment of children with severe hemophilia. In...
The aim of the thesis was to increase cost-effectiveness in prophylactic treatment of haemophilia. P...